U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07647250) titled 'Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy' on June 04.
Brief Summary: Patients with pancreatic cancer receiving neoadjuvant chemotherapy often experience functional decline, treatment interruptions, and clinical deterioration, and these risks may be amplified when frailty is present.
Study Start Date: Sept. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Physiological Reactivity to Cues
Physical Exercise
Intervention:
OTHER: 36-session targeted physical exercise program delivered twice weekly
Participant will be enrolled for approximately 18-20 weeks ...